Key Highlights from Thrombosis & Atherosclerosis Research Institute, Annual Report 2018-2020
![Feature image](https://healthsci.mcmaster.ca/wp-content/uploads/2023/07/dr-jeffrey-weitz.jpg)
TaARI remains focused on its mission to reduce death and disability from thrombotic diseases.
The Thrombosis & Atherosclerosis Research Institute (TaARI), located at the state-of-the-art research facility at the David Braley Research Building (DBRB) at the Hamilton General Hospital campus, has continued to maintain excellence in education and research under the leadership of Dr. Jeffrey Weitz, Executive Director. The DBRB is shared with the Population Health Research Institute (PHRI) with the goal of creating synergies between basic and clinical research, thereby enabling a seamless “bench to bedside and back again” approach to complex healthcare problems. TaARI laboratories have enabled new collaborations that extend to all hospital sites as well as national and international research collaborations.
TaARI remains focused on its mission to reduce death and disability from thrombotic diseases by conducting research into the pathogenesis, prevention, diagnosis and treatment of thrombosis and vascular disease and by providing an evidence-based platform for the education of the next generation of clinicians and scientists.
Please read more the full report here.
Dept. Med, Publications, ResearchRelated News
News Listing
![This composite image shows researchers Hong Han and Sheila Singh.](https://healthsci.mcmaster.ca/wp-content/uploads/2024/06/FHS24_CRC_Hong_Sheila_CC01.jpg)
Two Faculty of Health Sciences cancer researchers awarded Canada Research Chairs
Dept. Biochem, Dept. Surgery, Feature, Research
1 week ago
![Elena Verdu can be seen in this composite image. Verdu is smiling, wearing a green-coloured shirt and a necklace.](https://healthsci.mcmaster.ca/wp-content/uploads/2024/06/Elena-Verdu.jpg)
Elena Verdu appointed director of Farncombe Family Digestive Health Research Institute
Faculty & Staff, Research
1 week ago